Search Results - "Visseren, F L J"

Mechanisms linking obesity to hypertension by Dorresteijn, J. A. N, Visseren, F. L. J, Spiering, W

“…Obesity‐related hypertension is increasingly recognized as a distinct hypertensive phenotype requiring a modified approach to diagnosis and management. In this…”
Get full text

Diet in secondary prevention: the effect of dietary patterns on cardiovascular risk factors in patients with cardiovascular disease: a systematic review and network meta-analysis by Bonekamp, N E, Cruijsen, E, Geleijnse, J M, Winkels, R M, Visseren, F L J, Morris, P B, Koopal, C

“…Improving dietary habits is a first-line recommendation for patients with cardiovascular disease (CVD). It is unclear which dietary pattern most effectively…”
Get full text

Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management by van de Woestijne, A. P, Monajemi, H, Kalkhoven, E, Visseren, F. L. J

“…Elevated plasma triglyceride levels, as often seen in obese subjects, are independently associated with an increased risk of cardiovascular diseases. By…”
Get full text

Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men by Buddeke, J, Valstar, G B, van Dis, I, Visseren, F L J, Rutten, F H, den Ruijter, H M, Vaartjes, I, Bots, M L

“…To assess the trend in age- and sex-stratified mortality after hospitalization for heart failure (HF) in the Netherlands. Two nationwide cohorts of patients,…”
Get full text

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands by Pijlman, A.H, Huijgen, R, Verhagen, S.N, Imholz, B.P.M, Liem, A.H, Kastelein, J.J.P, Abbink, E.J, Stalenhoef, A.F.H, Visseren, F.L.J

“…Abstract Background Heterozygous familial hypercholesterolemia (heFH) is a common autosomal dominant hereditary disorder caused by mutations in the…”
Get full text

Obesity and risk of bleeding: the SMART study by Braekkan, S. K., Graaf, Y., Visseren, F. L. J., Algra, A.

“…Essentials Whether obesity protects against clinically relevant bleeding is unclear. We investigated the risk of bleeding according to various measures of…”
Get full text

Role of adipose tissue in haemostasis, coagulation and fibrinolysis by Faber, D.R, de Groot, Ph.G, Visseren, F.L.J

“…Obesity is associated with an increased incidence of insulin resistance (IR), type 2 diabetes mellitus and cardiovascular diseases. The increased risk for…”
Get full text

Cardiovascular risk prediction in HIV‐infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE‐NL) and Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) risk prediction models by Krikke, M, Hoogeveen, RC, Hoepelman, AIM, Visseren, FLJ, Arends, JE

“…Objectives The aim of the study was to compare the predictions of five popular cardiovascular disease (CVD) risk prediction models, namely the Data Collection…”
Get full text

Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies by Kanhai, D. A., Kranendonk, M. E., Uiterwaal, C. S. P. M., van der Graaf, Y., Kappelle, L. J., Visseren, F. L. J.

“…Summary The plasma concentration of adiponectin, an adipokine that has anti‐inflammatory, anti‐atherogenic and insulin sensitizing properties, is lower in…”
Get full text

Intracellular Infections Enhance Interleukin-6 and Plasminogen Activator Inhibitor 1 Production by Cocultivated Human Adipocytes and THP-1 Monocytes by Bouwman, J J M, Diepersloot, R J A, Visseren, F L J

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Relation between adiposity and vascular events, malignancy and mortality in patients with stable cerebrovascular disease by Jaspers, N E M, Dorresteijn, J A N, van der Graaf, Y, Westerink, J, Kappelle, L J, Nathoe, H M, Algra, A, Visseren, F L J

“…Background: Abdominal adiposity is associated with various risk factors including hypertension, and is therefore particularly relevant in patients with stable…”
Get full text

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients by Vlek, A L M, van der Graaf, Y, Spiering, W, Visseren, F L J

“…Patients with hypertension and manifest vascular disease are at high risk for recurrent cardiovascular diseases. It is unknown if the metabolic syndrome…”
Get full text

Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease by Koopal, C, van der Graaf, Y, Asselbergs, F W, Westerink, J, Visseren, F L J

“…Background: Apolipoprotein E ( APOE ) genotypes are associated with different plasma lipid levels. People with the APO ɛ2 genotype can develop a disorder…”
Get full text

The challenge of choosing in cardiovascular risk management by Hoogeveen, R. M., Hanssen, N. M. J., Brouwer, J. R., Mosterd, A., Tack, C. J., Kroon, A. A., de Borst, G. J., ten Berg, J., van Trier, T., van Lennep, J. Roeters, Liem, A., Serné, E., Visseren, F. L. J., Cornel, J. H., Peters, R. J. G., Jukema, J. W., Stroes, E. S. G.

“…Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. For many years guidelines have listed optimal preventive therapy. More…”
Get full text

Procoagulant and inflammatory response of virus-infected monocytes by Bouwman, J. J. M., Visseren, F. L. J., Bosch, M. C., Bouter, K. P., Diepersloot, R. J. A.

“…Background Monocytes play a prominent role in inflammation, coagulation and atherosclerosis by their ability to produce tissue factor (TF) and cytokines. The…”
Get full text

A computerised decision support system for cardiovascular risk management ‘live’ in the electronic health record environment: development, validation and implementation—the Utrecht Cardiovascular Cohort Initiative by Groenhof, T. K. J., Rittersma, Z. H., Bots, M. L., Brandjes, M., Jacobs, J. J. L., Grobbee, D. E., van Solinge, W. W., Visseren, F. L. J., Haitjema, S., Asselbergs, F. W.

“…Purpose We set out to develop a real-time computerised decision support system (CDSS) embedded in the electronic health record (EHR) with information on risk…”
Get full text

Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: The Second Manifestations of ARTerial (SMART) disease study by Beulens, J.W.J, Algra, A, Soedamah-Muthu, S.S, Visseren, F.L.J, Grobbee, D.E, van der Graaf, Y

“…Abstract Objective This study investigated the relation between alcohol consumption and specific vascular events and mortality in a high risk population of…”
Get full text

The metabolic syndrome: metabolic changes with vascular consequences by Wassink, A. M. J., Olijhoek, J. K., Visseren, F. L. J.

“…Despite criticism regarding its clinical relevance, the concept of the metabolic syndrome improves our understanding of both the pathophysiology of insulin…”
Get full text

Infection-induced inflammatory response of adipocytes in vitro by Bouwman, J.J.M, Visseren, F.L.J, Bouter, K.P, Diepersloot, R.J.A

“…Background: Abdominal obesity plays an important role in the development of insulin resistance, diabetes mellitus and atherosclerosis. The exact…”
Get full text

Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: the SMART study by Grool, A. M., van der Graaf, Y., Visseren, F. L. J., de Borst, G. J., Algra, A., Geerlings, M. I.

“…  Grool AM, van der Graaf Y, Visseren FLJ, de Borst GJ, Algra A, Geerlings MI, on behalf of the SMART Study Group (University Medical Center Utrecht, Utrecht,…”
Get full text